Aortic valve calcium as a novel risk marker for kidney function deterioration: The MESA study

Ashkan Abdollahi1, Maryam Mojarrad Sani1, Mahsima Shabani2

  • 1Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Insights

Aortic valve calcium (AVC) independently predicts a higher risk of developing chronic kidney disease (CKD). This finding highlights a potential link between cardiovascular calcification and kidney disease progression.

Area of Science:

  • Cardiology
  • Nephrology
  • Epidemiology

Background:

  • Aortic valve calcium (AVC) is linked to mortality and cardiovascular disease (CVD).
  • Traditional CVD risk factors are associated with both AVC and chronic kidney disease (CKD).
  • The relationship between AVC and incident CKD is not well understood.

Purpose of the Study:

  • To investigate if AVC, measured by cardiac CT, is independently associated with the long-term risk of incident CKD.
  • The study focused on individuals without a prior history of CVD.

Main Methods:

  • Analysis of 6346 Multi-Ethnic Study of Atherosclerosis (MESA) participants with baseline eGFR ≥ 60 mL/min/1.73 m².
  • AVC quantified by Agatston method; incident CKD defined by eGFR decline and/or ICD codes.
  • Kaplan-Meier analyses and multivariable Cox regression models used to assess the AVC-CKD association.

Main Results:

  • Over 16.9 years, 15% of participants developed incident CKD.
  • Higher AVC levels were associated with a significantly increased risk of developing CKD.
  • Participants with AVC ≥100 had a 48% higher risk of incident CKD compared to those with AVC=0 (HR 1.48).

Conclusions:

  • AVC is an independent predictor of increased risk for incident CKD in individuals without baseline CKD.
  • Further research is necessary to elucidate the complex interplay between AVC, CKD, and atherosclerosis.
Abstract